Nodysis Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 10-07-2024
- Paid Up Capital ₹ 1.35 Cr
as on 10-07-2024
- Company Age 22 Year, 15 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.53 M
as on 10-07-2024
- Satisfied Charges ₹ 1.57 Cr
as on 10-07-2024
About Nodysis Pharma
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.35 Cr.
The company currently has active open charges totaling ₹1.53 M. The company has closed loans amounting to ₹1.57 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sushil Sahu, Nilay Ghosh, Sujit Das, and Three other members serve as directors at the Company.
- CIN/LLPIN
U51397OR2002PTC006992
- Company No.
006992
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Dec 2002
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Company Details
- Location
Khorda, Odisha, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Nodysis Pharma Private Limited offer?
Nodysis Pharma Private Limited offers a wide range of products and services, including Vitamins & Supplements, Mineral Supplements.
Who are the key members and board of directors at Nodysis Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanat Meher  | Managing Director | 09-Dec-2002 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Tushar Pattnaik | Director | 24-Oct-2011 | Current |
| Prasanta Meher | Director | 24-Oct-2011 | Current |
| Sushil Sahu | Director | 24-Oct-2011 | Current |
| Nilay Ghosh | Director | 24-Oct-2011 | Current |
| Sujit Das | Director | 24-Oct-2011 | Current |
Financial Performance of Nodysis Pharma.
Nodysis Pharma Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Nodysis Pharma?
In 2017, Nodysis Pharma had a promoter holding of 96.67% and a public holding of 3.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Icici Bank Limited Creation Date: 31 Jul 2007 | ₹1.53 M | Open |
Reliance Capital Ltd Creation Date: 26 Nov 2011 | ₹2.41 M | Satisfied |
Reliance Capital Ltd Creation Date: 31 Jul 2008 | ₹2.92 M | Satisfied |
How Many Employees Work at Nodysis Pharma?
Nodysis Pharma has a workforce of 9 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nodysis Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nodysis Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
